Cargando...
EAPH-04. SAFETY AND TOLERABILITY OF CONCOMITANT MULTI-AGENT INTRA-VENTRICULAR CHEMOTHERAPY FOR THE TREATMENT OF RECURRENT CENTRAL NERVOUS SYSTEM (CNS) TUMORS
BACKGROUND: The safety of intra-ventricular or intrathecal monotherapy with topotecan, thiotepa and etoposide has previously been demonstrated in several publications. To our knowledge, the utility of the combination topotecan, thiotepa and etoposide through an intraventricular reservoir as a treatm...
Guardado en:
| Publicado en: | Neuro Oncol |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Oxford University Press
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6012973/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.173 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|